Chronic Lyme disease: in defense of the scientific enterprise.
There is no better example of a relentless attack on evidence-based biomedical research and the integrity of outstanding scientists than that associated with the treatment of a poorly defined condition called "chronic Lyme disease." Here, a scientifically naive general population, the lay press, and legislators, who in most instances are unable to evaluate and judge scientific evidence properly, have been misled by patient advocate groups to believe that extended antibiotic therapy is the best and only solution to this condition. This has resulted in the unprecedented intrusion of government and the legal systems into the practice of medicine and scientific research. Because there is no clinical evidence that this condition is due to a persistent infection, advocating extended antibiotic therapy is not justified and has been shown to be harmful and of no benefit.
Baker
Phillip J
PJ
American Lyme Disease Foundation, Lyme, CT 06371, USA. executivedir@aldf.com
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D002908:Chronic Disease / Q000188:drug therapy; D019317:Evidence-Based Medicine / Q000331:legislation & jurisprudence; D006801:Humans; D007348:Insurance, Health / Q000191:economics / Q000331:legislation & jurisprudence*; D008193:Lyme Disease / Q000188:drug therapy*; D013997:Time Factors
D000900:Anti-Bacterial Agents